{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T14:32:31Z","timestamp":1791210751960,"version":"4.1.0"},"reference-count":68,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2010,4,1]],"date-time":"2010-04-01T00:00:00Z","timestamp":1270080000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2010,4,1]],"date-time":"2010-04-01T00:00:00Z","timestamp":1270080000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annales Fran\u00e7aises d'Anesth\u00e9sie et de R\u00e9animation"],"published-print":{"date-parts":[[2010,4]]},"DOI":"10.1016\/j.annfar.2010.02.018","type":"journal-article","created":{"date-parts":[[2010,3,31]],"date-time":"2010-03-31T04:42:47Z","timestamp":1270010567000},"page":"e51-e58","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"title":["Principes g\u00e9n\u00e9raux de la prise en charge hospitali\u00e8re de la pr\u00e9\u00e9clampsie"],"prefix":"10.1016","volume":"29","author":[{"given":"P.","family":"Diemunsch","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.","family":"Langer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Noll","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.annfar.2010.02.018_bib1","doi-asserted-by":"crossref","first-page":"e47","DOI":"10.1016\/j.annfar.2010.02.017","article-title":"Prise en charge de la pr\u00e9\u00e9clampsie dans un r\u00e9seau de p\u00e9rinatalit\u00e9","volume":"29","author":"Winer","year":"2010","journal-title":"Ann Fr Anesth R\u00e9anim"},{"key":"10.1016\/j.annfar.2010.02.018_bib2","first-page":"131","article-title":"Bed rest in pregnancy","volume":"84","author":"Goldenberg","year":"1994","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.annfar.2010.02.018_bib3","first-page":"829","article-title":"Community-based home-care program for the management of pre-eclampsia: an alternative","volume":"149","author":"Helewa","year":"1993","journal-title":"CMAJ"},{"key":"10.1016\/j.annfar.2010.02.018_bib4","first-page":"1070","article-title":"Aggressive or expectant management for patients with severe preeclampsia between 28-34\u00a0weeks\u2019gestation: A randomized controlled trial","volume":"76","author":"Odendaal","year":"1990","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.annfar.2010.02.018_bib5","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1016\/0002-9378(94)90104-X","article-title":"Aggressive versus expectant management of severe preeclampsia at 28\u00a0to 32\u00a0weeks\u2019gestation: a randomized controlled trial","volume":"171","author":"Sibai","year":"1994","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.annfar.2010.02.018_bib6","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/0028-2243(92)90236-R","article-title":"Prognosis for preeclampsia complicated by 5g or more of proteinuria in 24hours","volume":"43","author":"Chua","year":"1992","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"10.1016\/j.annfar.2010.02.018_bib7","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/0028-2243(93)90032-8","article-title":"Management of severe, early pre-eclampsia: is conservative management justified?","volume":"51","author":"Olah","year":"1993","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"10.1016\/j.annfar.2010.02.018_bib8","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/0301-2115(95)02260-0","article-title":"Maternal and perinatal outcome of temporizing management in 254\u00a0consecutive patients with severe preeclampsia remote from term","volume":"63","author":"Visser","year":"1995","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"10.1016\/j.annfar.2010.02.018_bib9","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1067\/mob.2000.109049","article-title":"Expectant management of severe preterm preeclampsia: Is intrauterine growth restriction an indication for immediate delivery?","volume":"183","author":"Chammas","year":"2000","journal-title":"J Obstet Gynecol"},{"key":"10.1016\/j.annfar.2010.02.018_bib10","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.1111\/j.1471-0528.2000.tb11616.x","article-title":"Expectant management of early onset, severe preeclampsia; maternal outcome","volume":"107","author":"Hall","year":"2000","journal-title":"BJOG"},{"key":"10.1016\/j.annfar.2010.02.018_bib11","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1111\/j.1471-0528.2000.tb11617.x","article-title":"Expectant management of early onset, severe preeclampsia: perinatal outcome","volume":"107","author":"Hall","year":"2000","journal-title":"BJOG"},{"key":"10.1016\/j.annfar.2010.02.018_bib12","first-page":"24","article-title":"Expectant management of severe preeclampsia between 24\u00a0and 34\u00a0weeks\u2019gestation","volume":"107","author":"Vigil-DeGarcia","year":"2003","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"10.1016\/j.annfar.2010.02.018_bib13","doi-asserted-by":"crossref","first-page":"1590","DOI":"10.1016\/j.ajog.2004.03.050","article-title":"Maternal and perinatal outcomes during expectant management of 239\u00a0severe preeclamptic women between 24\u00a0and 33\u00a0weeks\u2019gestation","volume":"190","author":"Haddad","year":"2004","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.annfar.2010.02.018_bib14","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1016\/j.ajog.2004.10.621","article-title":"Should we offer expectant management in cases of severe preterm preeclampsia with fetal growth restriction?","volume":"192","author":"Shear","year":"2005","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.annfar.2010.02.018_bib15","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1111\/j.1471-0528.2004.00262.x","article-title":"Early onset severe preeclampsia: expectant management at a secondary hospital in close association with a tertiary institution","volume":"112","author":"Oettle","year":"2005","journal-title":"BJOG"},{"key":"10.1016\/j.annfar.2010.02.018_bib16","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1111\/j.1471-0528.2005.00687.x","article-title":"A randomized controlled trial comparing two temporizing management strategies, one with and one without plasma volume expansion, for severe and early onset pre-eclampsia","volume":"112","author":"Ganzevoort","year":"2005","journal-title":"BJOG"},{"key":"10.1016\/j.annfar.2010.02.018_bib17","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1111\/j.1471-0528.1997.tb11054.x","article-title":"Liver function tests in pre-eclampsia: importance of comparison with a reference range derived for normal pregnancy","volume":"104","author":"Girling","year":"1997","journal-title":"Br J Obstet Gynaecol"},{"key":"10.1016\/j.annfar.2010.02.018_bib18","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1016\/S0002-9378(87)80308-3","article-title":"Haptoglobin helps diagnose the HELLP syndrome","volume":"157","author":"Poldre","year":"1987","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.annfar.2010.02.018_bib19","doi-asserted-by":"crossref","unstructured":"National high blood pressure education program working group Report on high blood pressure in pregnancy. Am J Obstet Gynecol 1990;163:1689\u2013712.","DOI":"10.1016\/0002-9378(90)90653-O"},{"key":"10.1016\/j.annfar.2010.02.018_bib20","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajog.2007.02.021","article-title":"Expectant management of severe preeclampsia remote from term: patient selection, treatment, and delivery indications","volume":"196","author":"Sibai","year":"2007","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.annfar.2010.02.018_bib21","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1002\/uog.965","article-title":"Relationship between monitoring parameters and perinatal outcome in severe, early intrauterine growth restriction","volume":"23","author":"Bilardo","year":"2004","journal-title":"Ultrasound Obstet Gynecol"},{"key":"10.1016\/j.annfar.2010.02.018_bib22","first-page":"358","article-title":"Maternal deaths due to hypertensive disorders in pregnancy: Saving Mothers report 2002\u2013 2004","volume":"18","author":"Moodley","year":"2007","journal-title":"Cardiovasc J Afr"},{"key":"10.1016\/j.annfar.2010.02.018_bib23","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/S0301-2115(97)00112-7","article-title":"Increased concentrations of plasma epinephrine and norepinephrine in patients with eclampsia","volume":"74","author":"Khatun","year":"1997","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"10.1016\/j.annfar.2010.02.018_bib24","doi-asserted-by":"crossref","first-page":"145","DOI":"10.3109\/00016349209007974","article-title":"Fetal death following labetalol administration in pre-eclampsia","volume":"7","author":"Olsen","year":"1992","journal-title":"Acta Obstet Gynecol Scand"},{"key":"10.1016\/j.annfar.2010.02.018_bib25","doi-asserted-by":"crossref","unstructured":"Magpie Trial Collaboration Group. Do women with pre-eclampsia, and their babies, benefit from magnesium sulphate? The Magpie Trial: a randomised placebo-controlled trial. Lancet 2002;359:1877\u201390.","DOI":"10.1016\/S0140-6736(02)08778-0"},{"key":"10.1016\/j.annfar.2010.02.018_bib26","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1067\/mob.2000.106178","article-title":"Preeclampsia into eclampsia: toward a new paradigm","volume":"182","author":"Katz","year":"2000","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.annfar.2010.02.018_bib27","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1148\/radiology.217.2.r00nv44371","article-title":"Preeclampsia-eclampsia: clinical and neuroradiographic correlates and insights into the pathogenesis of hypertensive encephalopathy","volume":"217","author":"Schwartz","year":"2000","journal-title":"Radiology"},{"key":"10.1016\/j.annfar.2010.02.018_bib28","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1136\/bmj.304.6832.946","article-title":"Randomised controlled trial of atenolol and pindolol in human pregnancy: Effects on fetal haemodynamics","volume":"304","author":"Montan","year":"1992","journal-title":"Br Med J"},{"key":"10.1016\/j.annfar.2010.02.018_bib29","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1515\/jpme.1993.21.1.69","article-title":"Neonatal adaptation in hypertensive pregnancy-a study of labetalol vs hydralazine treatment","volume":"21","author":"Hjertberg","year":"1993","journal-title":"J Perinat Med"},{"key":"10.1016\/j.annfar.2010.02.018_bib30","first-page":"1","article-title":"Drugs for treatment of very high blood pressure during pregnancy (Review)","volume":"3","author":"Duley","year":"2006","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1016\/j.annfar.2010.02.018_bib31","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.ejogrb.2003.05.004","article-title":"Acute pulmonary oedema during nicardipine therapy for preterm labour; report of five cases","volume":"113","author":"Vaast","year":"2004","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"10.1016\/j.annfar.2010.02.018_bib32","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1111\/j.1471-0528.1993.tb15120.x","article-title":"Severe hypotension and fetal distress following sublingual administration of nifedipine to a patient with severe pregnancy induced hypertension at 33\u00a0weeks","volume":"100","author":"Impey","year":"1993","journal-title":"Br J Obstet Gynecol"},{"key":"10.1016\/j.annfar.2010.02.018_bib33","first-page":"354","article-title":"Nicardipine versus metoprolol in the treatment of hypertension during pregnancy: a randomized comparative trial","volume":"84","author":"Jannet","year":"1994","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.annfar.2010.02.018_bib34","first-page":"908","article-title":"Nicardipine treatment of hypertension during pregnancy","volume":"81","author":"Carbonne","year":"1993","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.annfar.2010.02.018_bib35","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1007\/s001340050100","article-title":"Intravenous nicardipine for severe hypertension in pre-eclampsia\u2013effects of an acute treatment on mother and foetus","volume":"25","author":"Aya","year":"1999","journal-title":"Intensive Care Med"},{"key":"10.1016\/j.annfar.2010.02.018_bib36","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1056\/NEJMoa021180","article-title":"Nimodipine Study Group. A comparison of magnesium sulfate and nimodipine for the prevention of eclampsia","volume":"348","author":"Belfort","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1016\/j.annfar.2010.02.018_bib37","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.1136\/bmj.318.7194.1332","article-title":"Fortnightly review: management of hypertension in pregnancy","volume":"318","author":"Magee","year":"1999","journal-title":"BMJ"},{"key":"10.1016\/j.annfar.2010.02.018_bib38","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/0020-7292(95)02372-J","article-title":"Oral nifedipine therapy in the management of severe preeclampsia","volume":"49","author":"Kwawukume","year":"1995","journal-title":"Int J Gynaecol Obstet"},{"key":"10.1016\/j.annfar.2010.02.018_bib39","first-page":"634","article-title":"Clonidine-hydrochloride \u2013 a safe and effective antihypertensive agent in pregnancy","volume":"66","author":"Horvath","year":"1985","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.annfar.2010.02.018_bib40","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/S0378-3782(88)80014-8","article-title":"Clonidine: placental transfer and neonatal adaptation","volume":"17","author":"Boutroy","year":"1988","journal-title":"Early Hum Dev"},{"key":"10.1016\/j.annfar.2010.02.018_bib41","doi-asserted-by":"crossref","first-page":"929","DOI":"10.2165\/00003495-199856050-00016","article-title":"Urapidil. A reappraisal of its use in the management of hypertension","volume":"56","author":"Dooley","year":"1998","journal-title":"Drugs"},{"key":"10.1016\/j.annfar.2010.02.018_bib42","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1016\/S0002-9378(99)70630-7","article-title":"Corticosteroid therapy for prevention of respiratory distress syndrome in severe preeclampsia","volume":"180","author":"Amorim","year":"1999","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.annfar.2010.02.018_bib43","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1056\/NEJM199910143411604","article-title":"Antenatal glucocorticoid treatment and cystic periventricular leukomalacia in very premature infants","volume":"341","author":"Baud","year":"1999","journal-title":"N Engl J Med"},{"key":"10.1016\/j.annfar.2010.02.018_bib44","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.ejogrb.2006.09.001","article-title":"Risk factors for acute pulmonary edema in preterm delivery","volume":"133","author":"Ogunyemi","year":"2007","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"10.1016\/j.annfar.2010.02.018_bib45","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1007\/BF03018719","article-title":"The therapeutic use of magnesium in anesthesiology, intensive care and emergency medicine: a review","volume":"50","author":"Dub\u00e9","year":"2003","journal-title":"Can J Anesth"},{"key":"10.1016\/j.annfar.2010.02.018_bib46","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1093\/bja\/83.2.302","article-title":"Magnesium: physiology and pharmacology","volume":"83","author":"Fawcett","year":"1999","journal-title":"Br J Anaesth"},{"key":"10.1016\/j.annfar.2010.02.018_bib47","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1213\/00000539-199201000-00021","article-title":"Clinical Use of Magnesium Infusions in Anesthesia","volume":"74","author":"James","year":"1992","journal-title":"Anesth Analg"},{"key":"10.1016\/j.annfar.2010.02.018_bib48","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1161\/01.HYP.0000146536.68208.84","article-title":"Magnesium inhibits norepinephrine release by blocking N-type calcium channels at peripheral sympathetic nerve endings","volume":"44","author":"Shimosawa","year":"2004","journal-title":"Hypertension"},{"key":"10.1016\/j.annfar.2010.02.018_bib49","first-page":"20","article-title":"Effects of magnesium on prostacyclin synthesis and intracellular free calcium concentration in vascular cells","volume":"17","author":"Satake","year":"2004","journal-title":"Magnes Res"},{"key":"10.1016\/j.annfar.2010.02.018_bib50","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1081\/PRG-45767","article-title":"Effect of magnesium on red blood cell deformability in pregnancy","volume":"24","author":"Schauf","year":"2005","journal-title":"Hypertens Pregnancy"},{"key":"10.1016\/j.annfar.2010.02.018_bib51","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1097\/01.AOG.0000244696.81795.3f","article-title":"Magnesium sulfate tocolysis: time to quit","volume":"109","author":"Macones","year":"2007","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.annfar.2010.02.018_bib52","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1097\/01.AOG.0000236445.18265.93","article-title":"Magnesium sulfate tocolysis: time to quit","volume":"108","author":"Grimes","year":"2006","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.annfar.2010.02.018_bib53","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1097\/00006254-199703000-00023","article-title":"Analysis of the risks associated with calcium channel blockade : implications for the obstetrician-gynecologist","volume":"52","author":"Davis","year":"1997","journal-title":"Obstet Gynecol Surv"},{"key":"10.1016\/j.annfar.2010.02.018_bib54","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1007\/BF03009168","article-title":"Calcium-channel blockers and anaesthesia","volume":"38","author":"Durand","year":"1991","journal-title":"Can J Anesth"},{"key":"10.1016\/j.annfar.2010.02.018_bib55","first-page":"327","article-title":"Magnesium sulphate for pre-eclampsia and a sudden bradycardia","volume":"85","author":"Pittman","year":"2000","journal-title":"Br J Anaesth"},{"key":"10.1016\/j.annfar.2010.02.018_bib56","first-page":"499","article-title":"Maternal deaths from anaesthesia. An extract from Why Mothers Die 1997\u20131999, the Confidential Enquiries into Maternal Deaths in the United Kingdom","volume":"89","author":"Thomas","year":"2002","journal-title":"Br J Anaesth"},{"key":"10.1016\/j.annfar.2010.02.018_bib57","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1016\/S0002-9378(96)70143-6","article-title":"Hemodynamic effects of oral nifedipine in preeclamptic hypertensive emergencies","volume":"175","author":"Scardo","year":"1996","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.annfar.2010.02.018_bib58","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.ajog.2004.11.059","article-title":"Therapy with both magnesium sulfate and nifedipine does not increase the risk of serious magnesium-related maternal side effects in women with preeclampsia","volume":"193","author":"Magee","year":"2005","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.annfar.2010.02.018_bib59","doi-asserted-by":"crossref","unstructured":"Magpie Trial Follow-Up Study Collaborative Group. The Magpie Trial: a randomised trial comparing magnesium sulphate with placebo for pre-eclampsia. Outcome for women at 2\u00a0years. BJOG 2007;114:300\u20139.","DOI":"10.1111\/j.1471-0528.2006.01166.x"},{"key":"10.1016\/j.annfar.2010.02.018_bib60","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1097\/00001721-200106000-00001","article-title":"Intravenous magnesium does not influence the activity of the coagulation cascade","volume":"12","author":"Ravn","year":"2001","journal-title":"Blood Coagul Fibrinolysis"},{"key":"10.1016\/j.annfar.2010.02.018_bib61","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1111\/j.1538-7836.2006.01999.x","article-title":"Magnesium sulfate neither potentiates nor inhibits tissue plasminogen activator-induced thrombolysis","volume":"4","author":"Stewart","year":"2006","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.annfar.2010.02.018_bib62","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1097\/00000539-200105000-00033","article-title":"The effect of magnesium on coagulation in parturients with preeclampsia","volume":"92","author":"Harnett","year":"2001","journal-title":"Anesth Analg"},{"key":"10.1016\/j.annfar.2010.02.018_bib63","unstructured":"R\u00e9animation des formes graves de pr\u00e9\u00e9clampsie. Conf\u00e9rence d\u2019experts de la Sfar. Paris: Elsevier; 2000."},{"key":"10.1016\/j.annfar.2010.02.018_bib64","unstructured":"Duley L, Williams J, Henderson-Smart DJ. Plasma volume expansion for treatment of pre-eclampsia (Cochrane Review). In: The Cochrane Library, Issue 4, 2002. Oxford: Update Software."},{"key":"10.1016\/j.annfar.2010.02.018_bib65","first-page":"240","article-title":"Cardiovascular alterations in severe pregnancy-induced hypertension seen with an intravenously given hydralazine bolus","volume":"161","author":"Cotton","year":"1985","journal-title":"Surg Gynecol Obstet"},{"key":"10.1016\/j.annfar.2010.02.018_bib66","unstructured":"Recommandations pour la pratique clinique Sfar-SRLF. Remplissage vasculaire au cours des hypovol\u00e9mies relatives ou absolues. Ann Fr Anesth R\u00e9anim 1997;16:8\u201314."},{"key":"10.1016\/j.annfar.2010.02.018_bib67","doi-asserted-by":"crossref","first-page":"e59","DOI":"10.1016\/j.annfar.2010.02.019","article-title":"Crit\u00e8res d\u2019arr\u00eat de la grossesse en cas de pr\u00e9\u00e9clampsie","volume":"29","author":"Haddad","year":"2010","journal-title":"Ann Fr Anesth R\u00e9anim"},{"key":"10.1016\/j.annfar.2010.02.018_bib68","doi-asserted-by":"crossref","unstructured":"Zupan-Simunek V. Pronostic des nouveau-n\u00e9s de m\u00e8re pr\u00e9\u00e9clamptique. Ann Fr Anesth R\u00e9anim 2010;29 (doi:10.1016\/j.annfar.2010.03.013).","DOI":"10.1016\/j.annfar.2010.03.013"}],"container-title":["Annales Fran\u00e7aises d'Anesth\u00e9sie et de R\u00e9animation"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0750765810000705?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0750765810000705?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T10:13:06Z","timestamp":1760091186000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0750765810000705"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,4]]},"references-count":68,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2010,4]]}},"alternative-id":["S0750765810000705"],"URL":"https:\/\/doi.org\/10.1016\/j.annfar.2010.02.018","relation":{},"ISSN":["0750-7658"],"issn-type":[{"value":"0750-7658","type":"print"}],"subject":[],"published":{"date-parts":[[2010,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Principes g\u00e9n\u00e9raux de la prise en charge hospitali\u00e8re de la pr\u00e9\u00e9clampsie","name":"articletitle","label":"Article Title"},{"value":"Annales Fran\u00e7aises d'Anesth\u00e9sie et de R\u00e9animation","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.annfar.2010.02.018","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2010 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}